Sun Pharmaceutical Inds. Ltd.
 
Bse Code: 524715 | NSE CODE: SUNPHARMA | Sector: Pharmaceuticals & Drugs
Prev Close
Open
MarketCap(` in Cr.)
Volume (No. of shares)
52 W LOW
52 W HIGH
LOW
HIGH

price chart

News

Experts suggest buying pharma stocks like DRL, Ranbaxy and Sun Pharma.
Asian shares gaining is positive for BSE Sensex. IMF lowers global growth forecast.

financial summary

` in Cr.MAR 2011MAR 2010yoy(%)
Net Sales3,104.702,485.5124.91
Total Expenditure1,782.061,590.3212.06
Operating Profit1,518.251,018.6349.05
Interest0.000.000.00
PBDT1,518.251,018.6349.05
Depreciation64.2369.47-7.54
PAT1,383.80898.6553.99

Research

Ratios

Earnings Per Share (Rs)13.36
Book NAV by Share(Rs)64.51
EBIT Margin(%)46.05
PAT Margin (%)43.83
ROCE(%)23.30
Price by Book(x)6.85
Yield(%)0.79
PAT Growth(%)53.99
Total Debt by Equity(x)0.01

More About this company on NDTV Profit

No Interviews/Opinions found.

announcement / Events


Dateannouncement / events
Apr 24, 2012
12:20 PM
Sun Pharma announces USFDA approval for generic Zyprexa tablets
May 15, 2012
12:45 PM
FY12 results on May 29, 2012
May 15, 2012
12:48 PM
Sun Pharma to announce Q4 and FY12 results on May 29, 2012
May 18, 2012
01:50 PM
Sun Pharma announces USFDA approval for generic Plavix tablets

shareholding pattern

DescriptionPercent of Share(%)
Total Promoter63.72
GovtN.A
FII19.97
Institutions25.49

Profit Board

No Post available.!

Corporate Information

Ashwin Dani
Director
Dilip S Shanghvi
Chairman
Sailesh T Desai
Whole Time Director
 
Registered Office:
Sun Pharma Advanced Research Centre (S P A R C)
Tandalja,
Vadodara,Gujarat.
Tel : 0265- 5515500 / 5515600 / 5515700
Fax : 0265- 2354897
 
Registrars Details:
Link Intime India Pvt Ltd
C-13 Pannalal Silk Compound,
L B S Marg,
Bhandup,
Mumbai

peer companies

MARKETS

TOP VIDEO

46:26